New study links blood proteins to Alzheimer’s disease and memory loss news.emory.edu/stories/2025/0…

Inspiring visit to ICIQ yesterday. Strengthening the links between #Chemistry and #Biomedicine research Institut d'Investigació i Innovació Parc Taulí Centres CERCA

🔬 Exciting to see Jordi Pujols present our disease-modifying approach for #Parkinson — HELICURE — developed with Irantzu Pallarès & Analia Bortolozzi , at Catalonia.Health #ConnectionDay2025. Step by step, we’re getting closer to making it a reality. Institut de Biotecnologia i de Biomedicina UAB Institut d'Investigació i Innovació Parc Taulí

Researchers have shed light on how small alpha-synuclein clumps disrupt brain cell membranes by forming pores in Parkinson’s disease. buff.ly/xGAt5UP

Happy to see an independent study using human cerebral organoids of synucleinopathy confirming our findings: SynuClean-D, a molecule developed in-house, dramatically reduces pathological α-synuclein and Tau. Always rewarding when others validate your work! mdpi.com/2073-4409/14/1…

SynuClean-D is full of surprises! 🎁 An independent study shows this in house developed molecule is a powerful ubiquitination inhibitor, with potential to treat Becker muscular dystrophy cell.com/molecular-ther…

🧬 El Parc Taulí avaluarà una nova teràpia per a la síndrome d'#Angelman 🔬 El centre participa en un assaig clínic internacional que busca millorar la qualitat de vida dels pacients abordant els trastorns del son, la comunicació i la motricitat 👉 tauli.cat/institut/actua…

Chaperone nanomotors with chemotactic ability for the treatment of Parkinson’s disease | Science Advances science.org/doi/10.1126/sc…

Mutation-induced filaments of folded proteins are inert and non-toxic in a cellular system | Molecular Systems Biology embopress.org/doi/full/10.10…

🧠 Alzheimer’s disease (AD) care is entering a new era. Promising new antibody treatments offer hope, but more research is needed to optimise their use. A new Lancet Series highlights crucial next steps in diagnosis, treatment, & prevention globally: hubs.ly/Q03K5-S40

🔎 Identificar quan el pacient i el ventilador no respiren de manera sincronitzada és clau per evitar lesions pulmonars. 👨‍💻 A la jornada de portes obertes, t'explicarem com hem desenvolupat un algoritme d’IA capaç de detectar-ho automàticament. 📅 9 d’octubre · 17.30h 📍 I3PT

This week we are at the Functional Amyloid Meeting at DESY (Deutsch) Hamburg. Old friends and great talks!!! Thanks Meytal Landau #FFFatDESY2025 Institut de Biotecnologia i de Biomedicina UAB Institut d'Investigació i Innovació Parc Taulí

🧠🔬 En el marc dels Matins i la Nit de la Recerca de la Universitat Autònoma de Barcelona, hem parlat de com la ciència bàsica és essencial per innovar en noves teràpies contra malalties neurodegeneratives com el Parkinson. La recerca és el primer pas cap a la cura. #RecercaUAB #Parkinson #Ciència

🏅L’I3PT compta amb 4 investigadors entre els més citats del món segons el World’s Top 2% Scientists List 2025 publicat per Stanford University i Elsevier En aquesta edició, el rànquing ha posicionat Antoni Artigas, Lluís Blanch, Ventura's Lab i Xavier Calvet tauli.cat/institut/actua…

Genetic and structural aspects of amyloid diseases | Science Translational Medicine science.org/doi/10.1126/sc…

Common Mechanism Underlying Synaptic Dysfunction Caused by Preformed Fibril-Induced Accumulation of α-Synuclein or Tau in a Culture Propagation Model | Journal of Neuroscience jneurosci.org/content/early/…

Huntington’s disease treated for first time using gene therapy nature.com/articles/d4158…

IDR-induced CAR condensation improves the cytotoxicity of CAR-Ts against low-antigen cancers | Nature Chemical Biology nature.com/articles/s4158…

Predicting protein-protein interactions in the human proteome | Science science.org/doi/10.1126/sc…

Us hi esperem!!!